A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
18 Years
N/A
Both
Lung Cancer
Trial Information
A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
Patients with lung cancer who have completed a course of treatment (or who are in-between
treatment) at the Royal Marsden Hospital would be eligible for inclusion in the study.
Participants will be randomised into 3 groups. Group 1 - this group will complete the QoL
questionnaire and will receive targeted therapies by a doctor (and other members of the
oncology team) during a clinic consultation. Group 2 - will complete the QoL questionnaire
however the questionnaire will not be seen by the doctor during a clinic consultation. Group
3 - the control group will not complete the QoL questionnaire before a clinic consultation.
All patients will complete a diary of all contact they have with health care professionals
during the study. The study will last for 6 weeks and at the end of the study all patients
will complete the QoL questionnaire.
Inclusion Criteria:
- male or female age > 18 years
- patients who are able to adequately understand written and spoken english
- diagnosis of lung cancer (non small cell, small cell, mesothelioma)
- no plan to commence treatment (chemotheraphy, targeted therapies, radioterhapy,
surgery) with 6 weeks
- both radically or palliatively treated patients remain eligible
- patients whose toxicities from their primary treatment has resolved or have
stabilised for a period of 7 days
Exclusion Criteria:
- patients are taking part on any other QoL studies
- taking part in any other studies that requires QoL questionnaires, extra visits or
investigations
- currently on treatment (chemotherapy, radiotherapy, surgery or targeted therapies)
- they have on going toxicities from their treatment which have not been stablised
(required intervention within last 7 days)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Outcome Measure:
To investigate whether the use of QOL questionnaires during the assessment and management of lung cancer patients results in improved quality of life
Safety Issue:
No
Principal Investigator
Dr M O'Brien
Investigator Role:
Principal Investigator
Investigator Affiliation:
Royal Marsden NHS Foundation Trust
Authority:
United Kingdom: Research Ethics Committee
Study ID:
CCR3454
NCT ID:
NCT01213745
Start Date:
September 2010
Completion Date:
July 2012
Related Keywords:
- Lung Cancer
- lung
- cancer
- quality of life
- Lung Neoplasms
Name | Location |
|---|
